Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant human proinsulin

EU orphan designation number: EU/3/08/612   
Active ingredient: Recombinant human proinsulin
Indication: Treatment of retinitis pigmentosa
Sponsor: ProRetina Therapeutics S.L.
Plaza Cein, 5, Despacho T5, E-31110 Noáin (Navarra), España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2009 Orphan designation EMEA/OD/087/08 (2009)1053 of 11/02/2009
22/06/2010 Change of name and/or address of sponsor EMEA/OD/087/08